<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36969178</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Alterations of the fecal and vaginal microbiomes in patients with systemic lupus erythematosus and their associations with immunological profiles.</ArticleTitle><Pagination><StartPage>1135861</StartPage><MedlinePgn>1135861</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1135861</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1135861</ELocationID><Abstract><AbstractText Label="BACKGROUND">Exploring the human microbiome in multiple body niches is beneficial for clinicians to determine which microbial dysbiosis should be targeted first. We aimed to study whether both the fecal and vaginal microbiomes are disrupted in SLE patients and whether they are correlated, as well as their associations with immunological features.</AbstractText><AbstractText Label="METHODS">A group of 30 SLE patients and 30 BMI-age-matched healthy controls were recruited. Fecal and vaginal samples were collected, the 16S rRNA gene was sequenced to profile microbiomes, and immunological features were examined.</AbstractText><AbstractText Label="RESULTS">Distinct fecal and vaginal bacterial communities and decreased microbial diversity in feces compared with the vagina were found in SLE patients and controls. Altered bacterial communities were found in the feces and vaginas of patients. Compared with the controls, the SLE group had slightly lower gut bacterial diversity, which was accompanied by significantly higher bacterial diversity in their vaginas. The most predominant bacteria differed between feces and the vagina in all groups. Eleven genera differed in patients' feces; for example, <i>Gardnerella</i> and <i>Lactobacillus</i> increased, whereas <i>Faecalibacterium</i> decreased. Almost all the 13 genera differed in SLE patients' vaginas, showing higher abundances except for <i>Lactobacillus</i>. Three genera in feces and 11 genera in the vagina were biomarkers for SLE patients. The distinct immunological features were only associated with patients' vaginal microbiomes; for example, <i>Escherichia-Shigella</i> was negatively associated with serum C4.</AbstractText><AbstractText Label="CONCLUSIONS">Although SLE patients had fecal and vaginal dysbiosis, dysbiosis in the vagina was more obvious than that in feces. Additionally, only the vaginal microbiome interacted with patients' immunological features.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Ling, Cheng, Gao, Lei, Yan, Hu, Shao, Liu and Kang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Zongxin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jinan Microecological Biomedicine Shandong Laboratory, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yiwen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Wenhui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Jinan Microecological Biomedicine Shandong Laboratory, Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Xiumei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Lishui Second People's Hospital, Lishui, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xiaogang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Lishui Second People's Hospital, Lishui, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Clinical Medicine, Institute of Hepatology and Metabolic Diseases, Hangzhou Normal University, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Runfang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Lishui Second People's Hospital, Lishui, Zhejiang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012336">RNA, Ribosomal, 16S</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012336" MajorTopicYN="N">RNA, Ribosomal, 16S</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014621" MajorTopicYN="N">Vagina</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">feces</Keyword><Keyword MajorTopicYN="N">immunology</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">vagina</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>19</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>27</Day><Hour>3</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36969178</ArticleId><ArticleId IdType="pmc">PMC10036376</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1135861</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis (2023) 82(3):351&#x2013;6. doi:&#xa0;10.1136/ard-2022-223035</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard-2022-223035</ArticleId><ArticleId IdType="pmc">PMC9933169</ArticleId><ArticleId IdType="pubmed">36241363</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber M, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, et al. . Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol (2021) 17(9):515&#x2013;32. doi:&#xa0;10.1038/s41584-021-00668-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00668-1</ArticleId><ArticleId IdType="pmc">PMC8982275</ArticleId><ArticleId IdType="pubmed">34345022</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen EY, Shaheen M, Woo J, Mercer N, Li N, McCurdy DK, et al. . 46-year trends in systemic lupus erythematosus mortality in the united states, 1968 to 2013: A nationwide population-based study. Ann Intern Med (2017) 167(11):777&#x2013;85. doi:&#xa0;10.7326/M17-0102</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M17-0102</ArticleId><ArticleId IdType="pmc">PMC6188647</ArticleId><ArticleId IdType="pubmed">29086801</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC. Systemic lupus erythematosus. N Engl J Med (2011) 365(22):2110&#x2013;21. doi:&#xa0;10.1056/NEJMra1100359</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1100359</ArticleId><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>James WA, Ogunrinde E, Wan Z, Kamen DL, Oates J, Gilkeson GS, et al. . A distinct plasma microbiome but not gut microbiome in patients with systemic lupus erythematosus compared to healthy individuals. J Rheumatol (2022) 49(6):592&#x2013;7. doi:&#xa0;10.3899/jrheum.210952</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.210952</ArticleId><ArticleId IdType="pmc">PMC9364828</ArticleId><ArticleId IdType="pubmed">35169056</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Wang H, Xu S, Zhuang Y, An J, Su C, et al. . Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut Microbes (2020) 11(6):1758&#x2013;73. doi:&#xa0;10.1080/19490976.2020.1768644</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1768644</ArticleId><ArticleId IdType="pmc">PMC7524333</ArticleId><ArticleId IdType="pubmed">32507008</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Shao T, Li H, Xie Z, Wen C. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog (2016) 8(1):64. doi:&#xa0;10.1186/s13099-016-0146-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-016-0146-9</ArticleId><ArticleId IdType="pmc">PMC5146896</ArticleId><ArticleId IdType="pubmed">27980687</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei F, Xu H, Yan C, Rong C, Liu B, Zhou H. Changes of intestinal flora in patients with systemic lupus erythematosus in northeast China. PloS One (2019) 14(3):e213063. doi:&#xa0;10.1371/journal.pone.0213063</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0213063</ArticleId><ArticleId IdType="pmc">PMC6417672</ArticleId><ArticleId IdType="pubmed">30870437</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang HF, Li X, Li HX, Zhang Q, Zhou HW, et al. . Disordered intestinal microbes are associated with the activity of systemic lupus erythematosus. Clin Sci (Lond) (2019) 133(7):821&#x2013;38. doi:&#xa0;10.1042/CS20180841</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180841</ArticleId><ArticleId IdType="pubmed">30872359</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Ren T, Li X, Zhai Q, Xu X, Zhang N, et al. . Distinct microbiomes of gut and saliva in patients with systemic lupus erythematous and clinical associations. Front Immunol (2021) 12:626217. doi:&#xa0;10.3389/fimmu.2021.626217</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.626217</ArticleId><ArticleId IdType="pmc">PMC8281017</ArticleId><ArticleId IdType="pubmed">34276643</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X, Edwards M, Mu Q, Yu Y, Vieson M, Reilly C, et al. . Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl Environ Microbiol (2018) 84(4):e2217&#x2013;88. doi:&#xa0;10.1128/AEM.02288-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02288-17</ArticleId><ArticleId IdType="pmc">PMC5795066</ArticleId><ArticleId IdType="pubmed">29196292</ArticleId></ArticleIdList></Reference><Reference><Citation>Hevia A, Milani C, Lopez P, Cuervo A, Arboleya S, Duranti S, et al. . Intestinal dysbiosis associated with systemic lupus erythematosus. Mbio (2014) 5(5):e1514&#x2013;48. doi:&#xa0;10.1128/mBio.01548-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01548-14</ArticleId><ArticleId IdType="pmc">PMC4196225</ArticleId><ArticleId IdType="pubmed">25271284</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin B, et al. . Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis (2019) 78(7):947&#x2013;56. doi:&#xa0;10.1136/annrheumdis-2018-214856</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214856</ArticleId><ArticleId IdType="pmc">PMC6585303</ArticleId><ArticleId IdType="pubmed">30782585</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Zhou H, Guo B, Chen W, Tao J, Cao N, et al. . Dysbiosis of oral microbiota is associated with systemic lupus erythematosus. Arch Oral Biol (2020) 113:104708. doi:&#xa0;10.1016/j.archoralbio.2020.104708</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archoralbio.2020.104708</ArticleId><ArticleId IdType="pubmed">32203722</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Wang J, Xiao Y, Wang X, Sun Q, Shang J, et al. . Saliva dysfunction and oral microbial changes among systemic lupus erythematosus patients with dental caries. BioMed Res Int (2018) 2018:8364042. doi:&#xa0;10.1155/2018/8364042</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/8364042</ArticleId><ArticleId IdType="pmc">PMC5902118</ArticleId><ArticleId IdType="pubmed">29808167</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Meulen T, Harmsen H, Vila A, Kurilshikov A, Liefers S, Zhernakova A, et al. . Shared gut, but distinct oral microbiota composition in primary sjogren&#x2019;s syndrome and systemic lupus erythematosus. J Autoimmun (2019) 97:77&#x2013;87. doi:&#xa0;10.1016/j.jaut.2018.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.009</ArticleId><ArticleId IdType="pubmed">30416033</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa J, Calderaro D, Ferreira G, Mendonca S, Fernandes G, Xiao E, et al. . Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status. Microbiome (2017) 5(1):34. doi:&#xa0;10.1186/s40168-017-0252-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0252-z</ArticleId><ArticleId IdType="pmc">PMC5359961</ArticleId><ArticleId IdType="pubmed">28320468</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Yi X, Long H, Zhang G, Wu H, Zhao M, et al. . Disordered cutaneous microbiota in systemic lupus erythematosus. J Autoimmun (2020) 108:102391. doi:&#xa0;10.1016/j.jaut.2019.102391</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102391</ArticleId><ArticleId IdType="pubmed">31883828</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Du J, Zhai Q, Hu J, Miller AW, Ren T, et al. . The bladder microbiome, metabolome, cytokines, and phenotypes in patients with systemic lupus erythematosus. Microbiol Spectr (2022) 10 (5):e21222. doi:&#xa0;10.1128/spectrum.00212-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00212-22</ArticleId><ArticleId IdType="pmc">PMC9620774</ArticleId><ArticleId IdType="pubmed">35913213</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Pang K, Wang J, Zhang B, Liu Z, Lu S, et al. . Microbiota dysbiosis in primary sj&#xf6;gren&#x2019;s syndrome and the ameliorative effect of hydroxychloroquine. Cell Rep (2022) 40(11):111352. doi:&#xa0;10.1016/j.celrep.2022.111352</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111352</ArticleId><ArticleId IdType="pubmed">36103827</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahren-Herlenius M, D&#xf6;rner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet (2013) 382(9894):819&#x2013;31. doi:&#xa0;10.1016/S0140-6736(13)60954-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60954-X</ArticleId><ArticleId IdType="pubmed">23993191</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldblatt F, O&#x2019;Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet (2013) 382(9894):797&#x2013;808. doi:&#xa0;10.1016/S0140-6736(13)61499-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61499-3</ArticleId><ArticleId IdType="pubmed">23993190</ArticleId></ArticleIdList></Reference><Reference><Citation>Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity (2007) 40(8):560&#x2013;6. doi:&#xa0;10.1080/08916930701510673</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930701510673</ArticleId><ArticleId IdType="pubmed">18075790</ArticleId></ArticleIdList></Reference><Reference><Citation>Zysset-Burri DC, Keller I, Berger LE, Largiad&#xe8;r CR, Wittwer M, Wolf S, et al. . Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. NPJ Genom Med (2020) 5:34. doi:&#xa0;10.1038/s41525-020-00141-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-020-00141-0</ArticleId><ArticleId IdType="pmc">PMC7463023</ArticleId><ArticleId IdType="pubmed">32922859</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaghlouth I, Johnson SR, Pullenayegum E, Gladman D, Urowitz M. Immunoglobulin levels in systemic lupus erythematosus: A narrative review. Lupus (2021) 30(6):867&#x2013;75. doi:&#xa0;10.1177/09612033211004714</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211004714</ArticleId><ArticleId IdType="pubmed">33779380</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehoud C, Rafail S, Tyldsley AS, Seykora JT, Lambris JD, Grice EA. Complement modulates the cutaneous microbiome and inflammatory milieu. Proc Natl Acad Sci U.S.A. (2013) 110(37):15061&#x2013;6. doi:&#xa0;10.1073/pnas.1307855110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1307855110</ArticleId><ArticleId IdType="pmc">PMC3773768</ArticleId><ArticleId IdType="pubmed">23980152</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation (2007) 115(7):928&#x2013;35. doi:&#xa0;10.1161/CIRCULATIONAHA.106.672402</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.672402</ArticleId><ArticleId IdType="pubmed">17309939</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc;demann L, Grieger W, Wurm R, Wust P, Zimmer C. Glioma assessment using quantitative blood volume maps generated by T1-weighted dynamic contrast-enhanced magnetic resonance imaging: a receiver operating characteristic study. Acta Radiol (2006) 47(3):303&#x2013;10. doi:&#xa0;10.1080/02841850500539033</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02841850500539033</ArticleId><ArticleId IdType="pubmed">16613313</ArticleId></ArticleIdList></Reference><Reference><Citation>Obuchowski NA. Receiver operating characteristic curves and their use in radiology. Radiology (2003) 229(1):3&#x2013;8. doi:&#xa0;10.1148/radiol.2291010898</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2291010898</ArticleId><ArticleId IdType="pubmed">14519861</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz CE. Basic principles of ROC analysis. Semin Nucl Med (1978) 8(4):283&#x2013;98. doi:&#xa0;10.1016/s0001-2998(78)80014-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0001-2998(78)80014-2</ArticleId><ArticleId IdType="pubmed">112681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health (2008) 31(2):180&#x2013;91. doi:&#xa0;10.1002/nur.20247</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nur.20247</ArticleId><ArticleId IdType="pubmed">18183564</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosca A, Leclerc M, Hugot JP. Gut microbiota diversity and human diseases: Should we reintroduce key predators in our ecosystem? Front Microbiol (2016) 7:455. doi:&#xa0;10.3389/fmicb.2016.00455</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00455</ArticleId><ArticleId IdType="pmc">PMC4815357</ArticleId><ArticleId IdType="pubmed">27065999</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu MB, Xu SR, He Y, Deng GH, Sheng HF, Huang XM, et al. . Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis. PloS One (2013) 8(11):e79812. doi:&#xa0;10.1371/journal.pone.0079812</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079812</ArticleId><ArticleId IdType="pmc">PMC3827160</ArticleId><ArticleId IdType="pubmed">24265786</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque MM, Merchant M, Kumar PN, Dutta A, Mande SS. First-trimester vaginal microbiome diversity: A potential indicator of preterm delivery risk. Sci Rep (2017) 7(1):16145. doi:&#xa0;10.1038/s41598-017-16352-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-16352-y</ArticleId><ArticleId IdType="pmc">PMC5700938</ArticleId><ArticleId IdType="pubmed">29170495</ArticleId></ArticleIdList></Reference><Reference><Citation>Manirarora JN, Kosiewicz MM, Alard P. Feeding lactobacilli impacts lupus progression in (NZBxNZW)F1 lupus-prone mice by enhancing immunoregulation. Autoimmunity (2020) 53(6):323&#x2013;32. doi:&#xa0;10.1080/08916934.2020.1777282</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2020.1777282</ArticleId><ArticleId IdType="pubmed">32552071</ArticleId></ArticleIdList></Reference><Reference><Citation>Toral M, Robles-Vera I, Romero M, de la Visitaci&#xf3;n N, S&#xe1;nchez M, O&#x2019;Valle F, et al. . Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus. FASEB J (2019) 33(9):10005&#x2013;18. doi:&#xa0;10.1096/fj.201900545RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201900545RR</ArticleId><ArticleId IdType="pubmed">31173526</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Q, Zhang H, Liao X, Lin K, Liu H, Edwards MR, et al. . Control of lupus nephritis by changes of gut microbiota. Microbiome (2017) 5(1):73. doi:&#xa0;10.1186/s40168-017-0300-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0300-8</ArticleId><ArticleId IdType="pmc">PMC5505136</ArticleId><ArticleId IdType="pubmed">28697806</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrova MI, Reid G, Vaneechoutte M, Lebeer S. Lactobacillus iners: Friend or foe? Trends Microbiol (2017) 25(3):182&#x2013;91. doi:&#xa0;10.1016/j.tim.2016.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2016.11.007</ArticleId><ArticleId IdType="pubmed">27914761</ArticleId></ArticleIdList></Reference><Reference><Citation>Severgnini M, Morselli S, Camboni T, Ceccarani C, Salvo M, Zagonari S, et al. . Gardnerella vaginalis clades in pregnancy: New insights into the interactions with the vaginal microbiome. PloS One (2022) 17(6):e269590. doi:&#xa0;10.1371/journal.pone.0269590</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0269590</ArticleId><ArticleId IdType="pmc">PMC9197028</ArticleId><ArticleId IdType="pubmed">35700195</ArticleId></ArticleIdList></Reference><Reference><Citation>Paramel JT, Schellenberg JJ, Hill JE. Resolution and characterization of distinct cpn60-based subgroups of gardnerella vaginalis in the vaginal microbiota. PloS One (2012) 7(8):e43009. doi:&#xa0;10.1371/journal.pone.0043009</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043009</ArticleId><ArticleId IdType="pmc">PMC3416817</ArticleId><ArticleId IdType="pubmed">22900080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, He Y, Liu L, Zhou W, Wang P, Hu H, et al. . Alterations in gut microbial communities across anatomical locations in inflammatory bowel diseases. Front Nutr (2021) 8:615064. doi:&#xa0;10.3389/fnut.2021.615064</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.615064</ArticleId><ArticleId IdType="pmc">PMC7952524</ArticleId><ArticleId IdType="pubmed">33718417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira-Halder CV, Faria A, Andrade SS. Action and function of faecalibacterium prausnitzii in health and disease. Best Pract Res Clin Gastroenterol (2017) 31(6):643&#x2013;8. doi:&#xa0;10.1016/j.bpg.2017.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpg.2017.09.011</ArticleId><ArticleId IdType="pubmed">29566907</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Chan T, Hong X, Zheng F, Zhu C, Yin L, et al. . Microbiome and metabolome analyses reveal the disruption of lipid metabolism in systemic lupus erythematosus. Front Immunol (2020) 11:1703. doi:&#xa0;10.3389/fimmu.2020.01703</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01703</ArticleId><ArticleId IdType="pmc">PMC7411142</ArticleId><ArticleId IdType="pubmed">32849599</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraelen H, Verhelst R, Vaneechoutte M, Temmerman M. Group a streptococcal vaginitis: an unrecognized cause of vaginal symptoms in adult women. Arch Gynecol Obstet (2011) 284(1):95&#x2013;8. doi:&#xa0;10.1007/s00404-011-1861-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-011-1861-6</ArticleId><ArticleId IdType="pubmed">21336834</ArticleId></ArticleIdList></Reference><Reference><Citation>Cools P. The role of escherichia coli in reproductive health: state of the art. Res Microbiol (2017) 168(9-10):892&#x2013;901. doi:&#xa0;10.1016/j.resmic.2017.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resmic.2017.02.002</ArticleId><ArticleId IdType="pubmed">28242352</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz-Agranov N, Zandman-Goddard G. The microbiome and systemic lupus erythematosus. Immunol Res (2017) 65(2):432&#x2013;7. doi:&#xa0;10.1007/s12026-017-8906-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-017-8906-2</ArticleId><ArticleId IdType="pubmed">28233089</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannon JR, Dunigan TL, Beebout CJ, Ross T, Wiebe MA, Reynolds WS, et al. . Invasion of vaginal epithelial cells by uropathogenic escherichia coli. Nat Commun (2020) 11(1):2803. doi:&#xa0;10.1038/s41467-020-16627-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16627-5</ArticleId><ArticleId IdType="pmc">PMC7272400</ArticleId><ArticleId IdType="pubmed">32499566</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>